Skip to main content
Redox Biology logoLink to Redox Biology
. 2023 Jul 14;65:102814. doi: 10.1016/j.redox.2023.102814

Corrigendum to “Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis” [Redox Biol. 46 (2021) 102082]

Ziwen Wang a,g, Long Chen a, Yu Huang a,b, Min Luo a,b, Huilan Wang a,c, Zhongyong Jiang a, Jiancheng Zheng a, Zeyu Yang d, Zelin Chen a, Chi Zhang a, Lei Long a, Yawei Wang a, Xueru Li e, Fengying Liao a, Yibo Gan a, Peng Luo a, Yunsheng Liu a, Yu Wang a, Xu Tan a, Ziyuan Zhou f, Aihua Zhang b, Chunmeng Shi a,
PMCID: PMC10461190  PMID: 37455180

The authors regret <that in Fig. 3C, the representative image showing HIF-1α (red) and nuclei (blue) in primary lung fibroblast treated with TGF-β1 + α-KG and TGF-β1 + IR-780, an error occurred while copying the picture, causing the author to paste the same image successively. The authors corrected the image in Fig. 3C for the group of TGF-β1 + IR-780. This correction does not impact the overall findings and conclusions of the paper. >.

Image 1

The authors would like to apologise for any inconvenience caused.


Articles from Redox Biology are provided here courtesy of Elsevier

RESOURCES